Found: 14
Select item for more details and to access through your institution.
Editorial: a clinical decision tool to identify patients who might benefit most from intensified dosing in the biological era—getting nearer? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 7, p. 738, doi. 10.1111/apt.15671
- By:
- Publication type:
- Article
Letter: are opioid prescriptions associated with hepatic encephalopathy in patients with compensated cirrhosis? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 7, p. 743, doi. 10.1111/apt.15669
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 7, p. 745, doi. 10.1111/apt.15668
- Publication type:
- Article
Advanced fibrosis is associated with incident cardiovascular disease in patients with non‐alcoholic fatty liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 7, p. 728, doi. 10.1111/apt.15660
- By:
- Publication type:
- Article
Editorial: glecaprevir/pibrentasvir for the treatment of hepatitis C virus—do baseline resistance‐associated substitutions matter? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 7, p. 741, doi. 10.1111/apt.15666
- By:
- Publication type:
- Article
Gamma delta<sup>+</sup> intraepithelial lymphocytes and coeliac lymphogram in a diagnostic approach to coeliac disease in patients with seronegative villous atrophy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 7, p. 699, doi. 10.1111/apt.15663
- By:
- Publication type:
- Article
Letter: are opioid prescriptions associated with hepatic encephalopathy in patients with compensated cirrhosis?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 7, p. 742, doi. 10.1111/apt.15661
- By:
- Publication type:
- Article
Systematic review with meta‐analysis: Saccharomyces boulardii for treating acute gastroenteritis in children—a 2020 update.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 7, p. 678, doi. 10.1111/apt.15659
- By:
- Publication type:
- Article
Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patients.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 7, p. 719, doi. 10.1111/apt.15665
- By:
- Publication type:
- Article
Editorial: glecaprevir/pibrentasvir for the treatment of hepatitis C virus—do baseline resistance‐associated substitutions matter?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 7, p. 739, doi. 10.1111/apt.15656
- By:
- Publication type:
- Article
Review article: faecal calprotectin and histologic remission in ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 7, p. 689, doi. 10.1111/apt.15662
- By:
- Publication type:
- Article
Editorial: a clinical decision tool to identify patients who might benefit most from intensified dosing in the biological era—getting nearer?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 7, p. 737, doi. 10.1111/apt.15634
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 7, p. 675, doi. 10.1111/apt.15343
- Publication type:
- Article
Prospective serial diagnostic study: the effects of position and provocative tests on the diagnosis of oesophageal motility disorders by high‐resolution manometry.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 7, p. 706, doi. 10.1111/apt.15658
- By:
- Publication type:
- Article